Literature DB >> 3338025

Interval-by-interval Cox model analysis of 3680 cases of intraocular melanoma shows a decline in the prognostic value of size and cell type over time after tumor excision.

J W Gamel1, I W McLean, R A Greenberg.   

Abstract

In a selected group of 3680 patients treated by ocular excision for uveal melanoma, 1178 deaths were attributed to this tumor during 20 years following ocular excision. Survival time was divided into intervals containing an equal number of deaths, and coefficients of the Cox statistical model were independently derived for each interval. This analysis revealed a statistically significant decline over time in the prognostic value of largest tumor dimension (LTD) and Callender cell type (CT). Mathematical considerations suggest that the prognostic value of parameters derived from other cancers may also decline with time following excision of the primary tumor.

Entities:  

Mesh:

Year:  1988        PMID: 3338025     DOI: 10.1002/1097-0142(19880201)61:3<574::aid-cncr2820610325>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  The molecular classification of uveal melanocytic lesions: an important discovery in context.

Authors:  Robert Folberg
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

2.  Cytomorphometry of uveal melanomas: fine needle aspiration biopsy versus standard histology.

Authors:  D H Char; S M Kroll; A Stoloff; J B Crawford; T R Miller; E L Howes; P Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Precision of ultrasonic estimates of choroidal melanoma regression.

Authors:  R Rask; P K Jensen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-12       Impact factor: 3.117

4.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

5.  DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.

Authors:  M Karlsson; B Boeryd; J Carstensen; B Kågedal; S Wingren
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.